D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$497M |
| 2 |
Bank of America
BAC
|
+$342M |
| 3 |
Costco
COST
|
+$332M |
| 4 |
Procter & Gamble
PG
|
+$332M |
| 5 |
Meta Platforms (Facebook)
META
|
+$305M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
+$504M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$387M |
| 3 |
Pfizer
PFE
|
+$366M |
| 4 |
Advanced Micro Devices
AMD
|
+$331M |
| 5 |
Walmart
WMT
|
+$320M |
Sector Composition
| 1 | Technology | 17.19% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Element Solutions
ESI
$6.36B
| $2.32M | ﹤0.01% |
130,266
+27,661
| +27% | +$492K |
|
|
GLHA
2002
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
| $2.31M | ﹤0.01% |
235,508
+169
| +0.1% | +$1.66K |
|
2003
Coupang
CPNG
$59.1B
| $2.31M | ﹤0.01% |
181,068
+135,012
| +293% | +$1.72M |
|
2004
Weis Markets
WMK
$1.75B
| $2.31M | ﹤0.01% |
30,946
+8,218
| +36% | +$613K |
|
2005
Expeditors International
EXPD
$16.8B
| $2.3M | ﹤0.01% |
23,643
-124,975
| -84% | -$12.2M |
|
2006
Angi Inc
ANGI
$760M
| $2.3M | ﹤0.01% |
50,250
+29,954
| +148% | +$1.37M |
|
2007
GoHealth
GOCO
$79.6M
| $2.28M | ﹤0.01% |
254,514
+4,804
| +2% | +$43.1K |
|
2008
Telkom Indonesia
TLK
$19B
| $2.28M | ﹤0.01% |
+84,397
| New | +$2.28M |
|
2009
European Wax Center
EWCZ
$169M
| $2.28M | ﹤0.01% |
129,158
+106,890
| +480% | +$1.88M |
|
2010
Kodak
KODK
$486M
| $2.27M | ﹤0.01% |
489,545
-605,472
| -55% | -$2.81M |
|
2011
Oric Pharmaceuticals
ORIC
$1.05B
| $2.27M | ﹤0.01% |
505,987
+261,088
| +107% | +$1.17M |
|
2012
Cytek Biosciences
CTKB
$501M
| $2.26M | ﹤0.01% |
210,802
-523,254
| -71% | -$5.61M |
|
|
FTII
2013
DELISTED
FutureTech II Acquisition Corp. Class A Common Stock
FTII
| $2.26M | ﹤0.01% |
+225,000
| New | +$2.26M |
|
2014
Leslie's
LESL
$62M
| $2.25M | ﹤0.01% |
147,983
+98,356
| +198% | +$1.49M |
|
|
AOGO
2015
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
| $2.24M | ﹤0.01% |
225,000
+100,000
| +80% | +$995K |
|
2016
Vodafone
VOD
$28.5B
| $2.24M | ﹤0.01% |
+143,650
| New | +$2.24M |
|
2017
Zeta Global
ZETA
$4.84B
| $2.23M | ﹤0.01% |
494,201
+211,943
| +75% | +$958K |
|
|
BCPC
2018
Balchem Corporation
BCPC
$5.07B
| $2.23M | ﹤0.01% |
17,201
+12,913
| +301% | +$1.68M |
|
|
DECA
2019
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
| $2.23M | ﹤0.01% |
+225,000
| New | +$2.23M |
|
|
ASCA
2020
DELISTED
A SPAC I Acquisition Corp. Class A Ordinary Share
ASCA
| $2.23M | ﹤0.01% |
225,000
+150,000
| +200% | +$1.49M |
|
|
BLTS
2021
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
| $2.23M | ﹤0.01% |
226,178
| – | – |
|
2022
CommScope
COMM
$3.61B
| $2.23M | ﹤0.01% |
363,563
-775,340
| -68% | -$4.75M |
|
|
TUYA
2023
Tuya Inc
TUYA
$1.57B
| $2.21M | ﹤0.01% |
843,729
+124,643
| +17% | +$327K |
|
2024
Hims & Hers Health
HIMS
$12.5B
| $2.21M | ﹤0.01% |
487,092
+462,511
| +1,882% | +$2.1M |
|
2025
Zumiez
ZUMZ
$347M
| $2.21M | ﹤0.01% |
84,858
+77,792
| +1,101% | +$2.02M |
|